Co-Authors
This is a "connection" page, showing publications co-authored by Marco Massari and Pamela Mancuso.
Connection Strength
0.527
-
Association of Influenza Vaccination and Prognosis in Patients Testing Positive to SARS-CoV-2 Swab Test: A Large-Scale Italian Multi-Database Cohort Study. Vaccines (Basel). 2021 Jul 01; 9(7).
Score: 0.238
-
Risk of coronavirus disease 2019 hospitalization and mortality in rheumatic patients treated with hydroxychloroquine or other conventional disease-modifying anti-rheumatic drugs in Italy. Rheumatology (Oxford). 2021 10 09; 60(SI):SI25-SI36.
Score: 0.061
-
Are Individuals with Substance Use Disorders at Higher Risk of SARS-CoV-2 Infection? Population-Based Registry Study in Northern Italy. Eur Addict Res. 2021; 27(4):263-267.
Score: 0.059
-
Acute-phase reactants during tocilizumab therapy for severe COVID-19 pneumonia. Clin Exp Rheumatol. 2020 Nov-Dec; 38(6):1215-1222.
Score: 0.057
-
Efficacy of tocilizumab in patients with COVID-19 ARDS undergoing noninvasive ventilation. Crit Care. 2020 09 29; 24(1):589.
Score: 0.057
-
Susceptibility and severity of COVID-19 in patients treated with bDMARDS and tsDMARDs: a population-based study. Ann Rheum Dis. 2020 07; 79(7):986-988.
Score: 0.055